2018 AHA/ACC guideline for the management of adults with congenital heart disease [Clinical Practice Guideline]
Journal article
Stout, Karen K., Daniels, Curt J., Aboulhosn, Jamil A., Bozkurt, Biykem, Broberg, Craig S., Colman, Jack M., Crumb, Stephen R., Dearani, Joseph A., Fuller, Stephanie, Gurvitz, Michelle Z., Khairy, Paul, Landzberg, Michael J., Saidi, Arwa, Valente, Anne Marie, Van Hare, George F. and Riegel, Barbara. (2019). 2018 AHA/ACC guideline for the management of adults with congenital heart disease [Clinical Practice Guideline]. Journal of the American College of Cardiology. 73(12), pp. 81 - 192. https://doi.org/10.1016/j.jacc.2018.08.1029
Authors | Stout, Karen K., Daniels, Curt J., Aboulhosn, Jamil A., Bozkurt, Biykem, Broberg, Craig S., Colman, Jack M., Crumb, Stephen R., Dearani, Joseph A., Fuller, Stephanie, Gurvitz, Michelle Z., Khairy, Paul, Landzberg, Michael J., Saidi, Arwa, Valente, Anne Marie, Van Hare, George F. and Riegel, Barbara |
---|---|
Abstract | [Extract] The 2018 ACHD guideline is a full revision of the “2008 ACC/AHA Guidelines for the Management of Adults with Congenital Heart Disease” (S1.4-1), which was the first U.S. guideline to be published on the topic. This revision uses the 2008 ACHD guideline as a framework and incorporates new data and growing ACHD expertise to develop recommendations. Congenital heart disease (CHD) encompasses a range of structural cardiac abnormalities present before birth attributable to abnormal fetal cardiac development but does not include inherited disorders that may have cardiac manifestations such as Marfan syndrome or hypertrophic cardiomyopathy. Also not included are anatomic variants such as patent foramen ovale. Valvular heart disease (VHD) may be congenital, so management overlaps with the “2014 AHA/ACC Guidelines for the Management of Patients With Valvular Heart Disease” (S1.4-2), particularly for bicuspid aortic valve (BAV) disease. Where overlap exists, this document focuses on the diagnosis and treatment of congenital valve disease when it differs from acquired valve disease, whether because of anatomic differences, presence of concomitant lesions, or differences to consider given the relatively young age of patients with ACHD. This guideline is not intended to apply to children (<18 years of age) with CHD or adults with acquired VHD, heart failure (HF), or other cardiovascular disease. |
Keywords | ACC/AHA Clinical Practice Guidelines; arrhythmias; cardiac catheterization; cardiac defects; congenital heart disease; congenital heart surgery; unoperated/repaired heart defect |
Year | 2019 |
Journal | Journal of the American College of Cardiology |
Journal citation | 73 (12), pp. 81 - 192 |
Publisher | Elsevier Inc. |
ISSN | 0735-1097 |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.jacc.2018.08.1029 |
Scopus EID | 2-s2.0-85063079127 |
Page range | 81 - 192 |
Research Group | Mary MacKillop Institute for Health Research |
Publisher's version | File Access Level Controlled |
Place of publication | United States of America |
https://acuresearchbank.acu.edu.au/item/8v88z/2018-aha-acc-guideline-for-the-management-of-adults-with-congenital-heart-disease-clinical-practice-guideline
Restricted files
Publisher's version
241
total views0
total downloads0
views this month0
downloads this month